Alzheimer’s Disease (AD) remains one of the most challenging neurological disorders, affecting millions worldwide. Its complex etiology and progression have puzzled scientists for decades. However, a recent study sheds light on several endogenous risk factors contributing to AD's development and progression, offering new insights into potential prevention and management strategies.

An article recently published by Dr. Kedar Prasad in the Journal of Neurological Disorders & Stroke

The article highlights a range of internal risk factors implicated in AD, including oxidative stress, chronic neuroinflammation, mitochondrial dysfunction, and more. Notably, the accumulation of beta-amyloids and the hyperphosphorylation of tau protein stand out as significant contributors to the disease's pathology. Dr. Prasad goes on to theorize his micronutrient centered approach coupled wiht CBD which has potential to synergize with existing treatments and may open new avenues for improving patient outcomes.

As we continue to unravel the complexities of AD, it's clear that our best hope lies in comprehensive strategies that consider the full scope of the disease. Through continued research and innovation, we can look forward to a future where Alzheimer's Disease no longer robs individuals of their memories and quality of life.

Prasad KN (2024) Attenuation of Beta-Amyloids and Other Risk Factors by a Micronutrient Mixture, Probiotics, Collagen Peptides,
Omega 3, and CBD in Alzheimer’s Disease. J Neurol Disord Stroke 11(2): 1219.